Since AxD is classified as an astrocytopathy (Borrett and Becker 1985; Brenner et al. 2009), in which mutant GFAP‐expressing astrocytes are drivers of white and gray matter deterioration (Messing et al. 2012), most research using animal models has focused on astrocytes. The gene discussed is GFAP; the disease is Alexander disease.